King, B., Soung, J., Tziotzios, C., Rudnicka, L., Joly, P., Gooderham, M., Sinclair, R., Anway, S., Wajsbrot, D., Lejeune, A. ., & Zwillich, S. (2023). Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) From the Phase 2 and Phase 3 ALLEGRO Clinical Trial Program. SKIN The Journal of Cutaneous Medicine, 7(6), s291. https://doi.org/10.25251/skin.7.supp.291